Electroconvulsive therapy in Parkinson's disease

Arquivos de neuro-psiquiatria
Humberto Calderón-FajardoMayela Rodríguez-Violante

Abstract

Purpose To analyze the effectiveness of electroconvulsive therapy for the management of depression and/or psychosis refractory to drug therapy in patients with Parkinson disease.Methods A retrospective study was carried out including patients treated with electroconvulsive therapy during the period between 2002 and 2013. A review of the literature was performed.Results A total of 27 patients were included. In regards to the neuropsychiatric diagnosis, 14 patients had major depression, 12 patients had both psychosis and depression, and only one patient had isolated psychosis. The mean number of electroconvulsive therapy sessions was 12 ± 2.8. After electroconvulsive therapy, all patients showed a statistically significant improvement in the Brief Psychiatric Rating scale (reduction of 52% points) and Hamilton Depression Rating Scale (reduction of 50% points) independent of the presence of psychosis, depression or both.Conclusion Electroconvulsive therapy is effective for the treatment of refractory neuropsychiatric symptoms in Parkinson's disease.

References

Jan 1, 1992·The Journal of Neuropsychiatry and Clinical Neurosciences·R HendersonP Como
Mar 14, 2003·Archives of Neurology·Dag AarslandPer Kragh-Sørensen
Nov 25, 2003·The Journal of Neuropsychiatry and Clinical Neurosciences·Richard KennedyJudith O'Jile
Aug 18, 2004·Journal of Geriatric Psychiatry and Neurology·Dylan P WintHubert H Fernandez
Nov 20, 2004·The Psychiatric Clinics of North America·Edward C Lauterbach
Oct 13, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Jose M RabeyColin Klein
Feb 3, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Bernard RavinaChristopher Goetz
Dec 14, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Connie MarrasUNKNOWN Parkinson Study Group DATATOP Investigators
Aug 8, 2009·Medical Hypotheses·Dennis Popeo, Charles H Kellner
Nov 12, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Claire L TomlinsonCarl E Clarke
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel Weintraub, David J Burn
Jul 21, 2011·Indian Journal of Psychiatry·K MuralidharanS Jain
Apr 13, 2012·Neurology·I H RichardUNKNOWN SAD-PD Study Group
May 19, 2012·BMJ Case Reports·Amin Muhammad Gadit, Thomas Smigas
Sep 7, 2012·Australasian Journal on Ageing·Sallyanne AaronsChanaka Wijeratne
Oct 9, 2012·The International Journal of Neuroscience·Louis Marino, Joseph H Friedman
May 9, 2014·The Journal of ECT·Samantha K CumperCharles H Kellner
May 14, 2014·The Journal of ECT·Pia BaldingerRupert Lanzenberger

❮ Previous
Next ❯

Citations

Jul 14, 2016·Neurodegenerative Disease Management·Daniel Martinez-RamirezMichael S Jaffee
Apr 9, 2020·Annals of Clinical and Translational Neurology·Christina PflugMonika Pötter-Nerger
Dec 7, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Akihiro TakamiyaTaishiro Kishimoto
Feb 26, 2021·The Journal of Neuropsychiatry and Clinical Neurosciences·Isaac RodinNicholas J Ainsworth
May 14, 2021·Movement Disorders Clinical Practice·Pedro J Garcia Ruiz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
R P Snaith
Movement Disorders : Official Journal of the Movement Disorder Society
Joseph Friedman
© 2021 Meta ULC. All rights reserved